This initiative aims to simplify EU legislation on medical devices and diagnostics to enhance competitiveness, foster innovation and ensure proportionate, cost-effective safety requirements while maintaining high levels of patient protection and public health.
Tuairimí atá idir lámha (updated on 15/12/2025) - Bureau decision date: 15/07/2025
This initiative seeks to revise EU CO₂ emission standards for new cars and vans to support a fact-based, economically viable and socially fair transition toward zero-emission mobility.
Tuairimí atá idir lámha (updated on 11/12/2025) - Bureau decision date: 22/10/2025
The new European Grids Package seeks to strengthen and modernise the EU’s energy infrastructure, ensuring secure, affordable and increasingly clean energy flows across Member States. It introduces a more coordinated planning framework, accelerates permitting, and enhances investment to support a fully interconnected and future-proof European energy system.
Tuairimí atá idir lámha (updated on 11/12/2025) - Bureau decision date: 02/12/2025
The Commission presents a proposal to enhance the control of drug precursors, the chemical substances that are used by both legitimate industries and in the production of illicit drugs. As Europe’s drug market evolves, the proposal strengthens authorities to respond to emerging drugs and production processes.
Tuairimí atá idir lámha (updated on 10/12/2025) - Bureau decision date: 18/09/2025
The opinion examines the digital omnibus, a set of two legislative proposals which focuses on bringing regulatory simplification and immediate relief to businesses active on digital.
Tuairimí atá idir lámha (updated on 08/12/2025) - Bureau decision date: 04/12/2025
This exploratory opinion on the request of the Cyprus Council presidency is focused on the implementation of the Startups and Scaleup Strategy, with particular emphasis on the forthcoming European Innovation Act (EIA), planned for 2026. The EU Startup and Scaleup Strategy seeks to make Europe the leading hub for launching and expanding global technology-driven companies, including deep tech ventures.
Tuairimí atá idir lámha (updated on 04/12/2025) - Bureau decision date: 22/10/2025
The exploratory opinion examines how to balance the economic benefits of tourism with the protection of local communities by regulating short-term rentals, mitigating over-tourism, strengthening connectivity, and promoting sustainable, inclusive tourism across Europe.
Tuairimí atá idir lámha (updated on 04/12/2025) - Bureau decision date: 13/12/2022
The initiative revises the Cybersecurity Act to clarify ENISA’s mandate, strengthen EU cybersecurity certification, simplify legislation, and support a secure and resilient European supply chain and industrial base.
Tuairimí atá idir lámha (updated on 03/12/2025) - Bureau decision date: 16/09/2025
The opinion analyses the legislative proposal on the EU Business Wallet which aims at enabling secure digital identification, data sharing and legally valid notifications across the EU. Its purpose is to help economic operators manage regulatory requirements, cut administrative burdens and compliance costs. By ensuring interoperability with national systems, it also aims at supporting cross-border business, boosting SME competitiveness, fostering trust in digital interactions and advancing the EU’s digital single market.
Tuairimí atá idir lámha (updated on 01/12/2025) - Bureau decision date: 22/10/2025
This opinion is prepared at the request of the incoming Cypriot Presidency of the EU. The EESC was invited to deliver an opinion on how the EU and its Member States can best:
1. Introduce and promote effective tools, including AI-based solutions, to enhance the quality of employment and working conditions, ensuring transparency, fairness, and accountability in their use.
2. Strengthen social dialogue and collective bargaining as fundamental mechanisms for shaping fair and inclusive labour markets in a rapidly changing economic and technological context.
Tuairimí atá idir lámha (updated on 28/11/2025) - Bureau decision date: 16/09/2025
The upcoming Cyprus Presidency of the Council of the EU has asked the EESC to draw up an exploratory opinion aimed at providing insight and recommendation on the establishment of the European centre of clinical excellence for pharmaceuticals, with the view to serve as a unified, evidence-based authority issuing pharmacotherapy recommendations, guidelines, and protocols for a wide range of diseases.
Tuairimí atá idir lámha (updated on 20/11/2025) - Bureau decision date: 22/10/2025
